Bradley Hargreaves
Chief Operating Officer chez XC Velle Institute, Inc.
Fortune : 160 256 $ au 31/03/2024
Profil
Bradley Hargreaves is currently the Operations Director & Principal at XC Velle Institute, Inc. and the Director, VP-Technology & Operations at Cell MedX (Canada) Corp.
He previously worked as the Director at Cell MedX Corp.
from 2023 to 2024.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CELL MEDX CORP.
1,81% | 07/02/2024 | 5 341 855 ( 1,81% ) | 160 256 $ | 31/03/2024 |
Postes actifs de Bradley Hargreaves
| Sociétés | Poste | Début |
|---|---|---|
| XC Velle Institute, Inc. | Chief Operating Officer | 01/01/2009 |
Cell MedX (Canada) Corp.
 Cell MedX (Canada) Corp. Pharmaceuticals: MajorHealth Technology Part of Cell MedX Corp., Cell MedX (Canada) Corp. is a Canadian pharmaceutical company. The private company is based in Vancouver, Canada. The CEO of the company is Frank E. Mcenulty. | Chief Tech/Sci/R&D Officer | - |
Anciens postes connus de Bradley Hargreaves
| Sociétés | Poste | Fin |
|---|---|---|
| CELL MEDX CORP. | Chief Tech/Sci/R&D Officer | 12/12/2023 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CELL MEDX CORP. | Health Technology |
| Entreprise privées | 2 |
|---|---|
| XC Velle Institute, Inc. | |
Cell MedX (Canada) Corp.
Cell MedX (Canada) Corp. Pharmaceuticals: MajorHealth Technology Part of Cell MedX Corp., Cell MedX (Canada) Corp. is a Canadian pharmaceutical company. The private company is based in Vancouver, Canada. The CEO of the company is Frank E. Mcenulty. | Health Technology |
